Kewaunee Scientific Corporation KEQU
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.23M | 9.62M | 11.08M | 11.74M | 12.31M |
| Total Depreciation and Amortization | 6.32M | 6.28M | 6.02M | 5.99M | 5.21M |
| Total Amortization of Deferred Charges | 529.00K | 567.00K | 1.01M | 685.00K | 591.00K |
| Total Other Non-Cash Items | 2.08M | 2.36M | 2.18M | 1.29M | 1.58M |
| Change in Net Operating Assets | -2.35M | -194.00K | 2.30M | -11.04M | 1.68M |
| Cash from Operations | 14.82M | 18.63M | 22.58M | 8.67M | 21.37M |
| Capital Expenditure | -3.94M | -3.94M | -3.53M | -3.55M | -2.66M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | -28.74M | -28.74M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.94M | -3.94M | -3.53M | -32.28M | -31.39M |
| Total Debt Issued | 43.03M | 26.61M | 26.28M | 27.95M | 51.38M |
| Total Debt Repaid | -60.82M | -44.93M | -42.79M | -16.10M | -42.42M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2.23M | -671.00K | -2.27M | -2.27M | -1.60M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -339.00K | -339.00K | -1.94M | -1.60M | -1.76M |
| Cash from Financing | -20.36M | -19.33M | -20.71M | 7.98M | 5.61M |
| Foreign Exchange rate Adjustments | -698.00K | -917.00K | -329.00K | -352.00K | -324.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.18M | -5.55M | -1.99M | -15.99M | -4.75M |